日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intratumoral dendritic cell immunotherapy controls dissemination of metastasis-initiating cancer cells, even in patients with metastatic breast cancer

肿瘤内树突状细胞免疫疗法可以控制转移起始癌细胞的扩散,即使在转移性乳腺癌患者中也是如此。

Soyano, Aixa; Lee, Marie Catherine; Han, Hyo S; Aldrich, Amy; Soliman, Hatem; Olson-Mcpeek, Sy K; Balsay-Patel, Caitlyn N; Aiello, Paige; Farrell, Carly M; Weinfurtner, Robert; Burgos, Eliana; Czerniecki, Brian J; Ramamoorthi, Ganesan

CRISPR-Enhanced RAA-SHERLOCK Assay for Point-of-Care Detection of Cyprinid Herpesvirus-3: Development, Validation and Clinical Application

CRISPR增强型RAA-SHERLOCK检测方法用于即时检测鲤疱疹病毒3型:开发、验证和临床应用

Soliman, Hatem; Akram, Naveed; Saleh, Mona

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial

在 I-SPY 临床试验中识别与后续免疫相关不良事件相关的早期症状

Basu, Amrita; Umashankar, Saumya; Melisko, Michelle; Roy, Ritu; Yau, Christina; Pusztai, Lajos; Chien, A Jo; Liu, Minetta; Han, Hyo; Soliman, Hatem; Isaacs, Claudine; Shatsky, Rebecca; Stringer-Reasor, Erica; Robinson, Patricia; Yeung, Kay; Kalinsky, Kevin; Thomas, Alexandra; Philip, Errol; Musthafa, Mina; Hirst, Gillian; Asare, Adam; DeMichele, Angela; Van't Veer, Laura; Yee, Douglas; Hylton, Nola; Olshen, Adam; Perlmutter, Jane; Cohen, Ronald N; Quandt, Zoe; Esserman, Laura; Hershman, Dawn; Rugo, Hope; Nanda, Rita

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

Tucatinib 和 trastuzumab 治疗 HER2 突变转移性乳腺癌:一项 II 期篮式试验

Okines, Alicia F C; Curigliano, Giuseppe; Mizuno, Nobumasa; Oh, Do-Youn; Rorive, Andree; Soliman, Hatem; Takahashi, Shunji; Bekaii-Saab, Tanios; Burkard, Mark E; Chung, Ki Y; Debruyne, Philip R; Fox, Jenny R; Gambardella, Valentina; Gil-Martin, Marta; Hamilton, Erika P; Monk, Bradley J; Nakamura, Yoshiaki; Nguyen, Danny; O'Malley, David M; Olawaiye, Alexander B; Pothuri, Bhavana; Reck, Martin; Sudo, Kazuki; Sunakawa, Yu; Van Marcke, Cedric; Yu, Evan Y; Ramos, Jorge; Tan, Sherry; Bieda, Mark; Stinchcombe, Thomas E; Pohlmann, Paula R

Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial

ERBB2乳腺癌化疗前肿瘤内树突状细胞对肿瘤微环境的改变:一项非随机临床试验

Han, Hyo S; Aldrich, Amy L; Garg, Saurabh K; Weinfurtner, R Jared; Nguyen, Jonathan V; Mo, Qianxing; Whiting, Junmin; Childress, Jennifer; Soliman, Hatem; Costa, Ricardo; Armaghani, Avan; Soyano, Aixa; Kiluk, John; Hoover, Susan; Lee, Marie C; Khakpour, Nazanin; Shenoi, Nithin; Jameel, Zena; Koski, Gary K; Czerniecki, Brian J

Phase II trial of brain MRI surveillance in stage IV breast cancer

IV期乳腺癌脑部MRI监测的II期试验

Ahmed, Kamran A; Kim, Youngchul; Armaghani, Avan J; Arrington, John A; Costa, Ricardo L; Czerniecki, Brian J; Diaz, Roberto; Dowell, Robin A; Extermann, Martine; Forsyth, Peter A; Lee, Kimberley T; Loftus, Loretta; Mills, Matthew N; Phuoc, Vania H; Rosa, Marilin; Soliman, Hatem H; Sam, Christine S; Washington, Iman R; Soyano, Aixa E; Han, Hyo S

Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

纳武利尤单抗联合立体定向放射外科治疗乳腺癌脑转移患者:一项非随机、开放标签的 Ib 期研究的长期结果和生物标志物分析

Ahmed, Kamran A; Kim, Younchul; Kim, Sungjune; Wang, Min Hsuan; DeJesus, Michelle; Arrington, John A; Soyano, Aixa E; Armaghani, Avan J; Costa, Ricardo L B; Loftus, Loretta S; Rosa, Marilin; Caudell, Jimmy J; Diaz, Roberto; Etame, Arnold B; Tran, Nam D; Soliman, Hatem; Czerniecki, Brian J; Forsyth, Peter A; Yu, Hsiang-Hsuan Michael; Han, Hyo S

A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer

一项将靶向HER2的树突状细胞纳入早期HER2+ER-乳腺癌新辅助治疗的试点研究

Soliman, Hatem; Aldrich, Amy; Abdo, Neveen; Han, Hyo; Soyano, Aixa; Costa, Ricardo; Armaghani, Avan; Kiluk, John; Khakpour, Nazanin; Lee, Marie Catherine; Hoover, Susan; Laronga, Christine; Niell, Bethany; Mooney, Blaise; Weinfurtner, Robert Jared; Rosa, Marilin; Czerniecki, Brian

Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial

免疫亚型分析可识别对新辅助免疫疗法(IO)有反应的激素受体阳性早期乳腺癌患者:I-SPY2试验五个IO组的结果

Wolf, Denise M; Yau, Christina; Campbell, Michael; Glas, Annuska; Barcaru, Andrei; Mittempergher, Lorenza; Kuilman, Midas; Brown-Swigart, Lamorna; Hirst, Gillian; Basu, Amrita; Magbanua, Mark; Sayaman, Rosalyn; Huppert, Laura; Delson, Amy; Symmans, W Fraser; Borowsky, Alexander; Pohlmann, Paula; Rugo, Hope; Clark, Amy; Yee, Douglas; DeMichele, Angela; Perlmutter, Jane; Petricoin, Emmanuel F; Chien, Jo; Stringer-Reasor, Erica; Shatsky, Rebecca; Liu, Minetta; Han, Hyo; Soliman, Hatem; Isaacs, Claudine; Nanda, Rita; Hylton, Nola; Pusztai, Lajos; Esserman, Laura; van 't Veer, Laura

2025 Kidney Cancer Research Summit Abstracts

2025年肾癌研究峰会摘要

Joh, Jennifer E; Esposito, Nicole N; Kiluk, John V; Laronga, Christine; Lee, M Catherine; Loftus, Loretta; Soliman, Hatem; Boughey, Judy C; Reynolds, Carol; Lawton, Thomas J; Acs, Peter I; Gordan, Lucio; Acs, Geza; Gupta, Shikha